FindMyKOL

Alain Bouchard, MD

Basic profile

Princeton Baptist Medical Center

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionBirmingham, AL · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Alain Bouchard is a Cardiology physician affiliated with Princeton Baptist Medical Center. OpenAlex indexes 43 publications with 3,038 citations (h-index 25).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
43publications

Publications indexed by OpenAlex. Counts exclude supporting files.

3,038citations

Citations across these publications.

25h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
23companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Janssen
    Program year202515 paymentsResearch
    $231,481
  • Novartis
    Program year20258 paymentsResearch
    $201,859
  • Amgen
    Program year20254 paymentsResearch
    $79,364
All 47 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.7%
    Beta blocker16.1%
    Metoprolol Succinate71%Carvedilol10%Metoprolol Tartrate9%Atenolol3%Sotalol3%Pindolol2%Nebivolol Hcl1%Bisoprolol Fumarate1%Labetalol Hcl1%
    Part D<11 patients
    Statin15.1%
    Rosuvastatin Calcium58%Atorvastatin Calcium30%Pravastatin Sodium9%Simvastatin2%Livalo1%
    Part D<11 patients

    + 19 more classes in this area

  • Blood & clotting

    14.6%
    Factor Xa inhibitor8.8%
    Eliquis90%Xarelto10%
    Part D≥138 patients
    P2Y12 inhibitor4.9%
    Clopidogrel92%Prasugrel Hcl8%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    8.5%
    SGLT2 inhibitor5.3%
    Jardiance89%Farxiga11%
    Part D≥113 patients
    Proton pump inhibitor2%
    Pantoprazole Sodium82%Esomeprazole Magnesium10%Omeprazole8%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)1.2% facility · 98.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”